These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18808421)

  • 1. p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis.
    Yachida S; Sakamoto M; Imaida K; Yokohira M; Saoo K; Okano K; Wakabayashi H; Maeta H; Suzuki Y
    Cancer Sci; 2008 Nov; 99(11):2152-9. PubMed ID: 18808421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
    Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis.
    Yachida S; Imaida K; Yokohira M; Hashimoto N; Suzuki S; Okano K; Wakabayashi H; Maeta H; Suzuki Y
    Ann Surg Oncol; 2010 Dec; 17(12):3386-93. PubMed ID: 20589433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27
    Cigliano A; Simile MM; Vidili G; Pes GM; Dore MP; Urigo F; Cossu E; Che L; Feo C; Steinmann SM; Ribback S; Pascale RM; Evert M; Chen X; Calvisi DF
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064589
    [No Abstract]   [Full Text] [Related]  

  • 6. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma.
    Xu H; Choe C; Shin SH; Park SW; Kim HS; Jung SH; Yim SH; Kim TM; Chung YJ
    Exp Mol Med; 2014 May; 46(5):e97. PubMed ID: 24854087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and hypermethylation of p27 kip1 in hepatocarcinogenesis.
    Lei PP; Zhang ZJ; Shen LJ; Li JY; Zou Q; Zhang HX
    World J Gastroenterol; 2005 Aug; 11(29):4587-91. PubMed ID: 16052694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray.
    Li SH; Li CF; Sung MT; Eng HL; Hsiung CY; Huang WW; Lin CN; Yu SC; Huang HY
    Mod Pathol; 2007 Apr; 20(4):497-507. PubMed ID: 17384652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF; Ng IO
    Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
    Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
    Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
    Shehata MA; Nosseir HR; Nagy HM; Farouk G
    Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.
    Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH
    World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.
    Matsuda Y
    World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.
    Ranchal I; González R; Bello RI; Ferrín G; Hidalgo AB; Linares CI; Aguilar-Melero P; González-Rubio S; Barrera P; Marchal T; Nakayama KI; de la Mata M; Muntané J
    Int J Cancer; 2009 Nov; 125(10):2270-80. PubMed ID: 19672859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
    Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.